Reduced-energy diet in women with gestational diabetes: the dietary intervention in gestational diabetes DiGest randomized clinical trial.

Name: Αlpha¹ Rigor Record — Reduced-energy diet in women with gestational diabetes: the dietary intervention in gestational diabetes DiGest randomized clinical trial.
Item: Reduced-energy diet in women with gestational diabetes: the dietary intervention in gestational diabetes DiGest randomized clinical trial.
Rating: 59
Author: Αlpha¹

Kusinski LC, Jones D, Atta N, Turner E, Smith S, Oude Griep LM, Rennie K, De Lucia Rolfe E, Sharp SJ, Farewell V, Murphy HR, Taylor R, Meek CL

Paper source

Read full text (PMC)

Embed this Rigor badge

Αlpha¹ Rigor Review — 1★ (Critical), 0 critical, 4 high issues for “Reduced-energy diet in women with gestational diabetes: the dietary intervention in gestational diabetes DiGest randomized clinical trial.”

Links back to this Rigor Record.

Αlpha¹ Editorial

This rigor review was examined and confirmed by Αlpha¹ Editorial · August 15, 2026

Αlpha¹ Rigor Review

Rigor Reviewed

1 / 5

Critical — serious problems across many checks

Interventional Study

Critical

High-priority

How this rating was calculated▸

Started at 5★ — deductions

IntegrityIntegrity concern ×3−1.5★
ClaimsOverstated claim ×2−1★
StatisticsStatistic did not reproduce−0.5★
ClaimsEfficacy rests on an unvalidated surrogate endpoint−0.5★
ClaimsTreatment effect not shown to be clinically meaningful−0.5★
ReportingData & code availability partially met−0.25★

Model-reported confidence: highReviewer agreement: highEngine: 7.39.0Source: full text

Problems surfaced7 types

Numerical inconsistencies2

Values that contradict each other or are impossible for the stated sample: recomputed p-values and test statistics, GRIM/GRIMMER checks on summary numbers, percentages against their own counts, totals against their parts, and estimates against their own confidence intervals.

Summary statistic impossible for the stated N (GRIM/GRIMMER)Recomputed
Internal contradictions in the reported numbersAssessed

Overstated conclusions4

Conclusions that reach past what the paper's own results support — including a significance claim that no longer holds when the statistic is recomputed, and efficacy resting on an unvalidated surrogate endpoint.

Efficacy rests on an unvalidated surrogate endpointAssessed
Treatment effect not shown to be clinically meaningfulAssessed
Conclusions overstated beyond the evidenceAssessed
Conclusions only partially backed by the presented evidenceAssessed

Reporting gaps1

Required detail the manuscript never states — study design, biological variables, ethics approval and consent, key resources, statistical reporting, data and code availability, and overall transparency.

Data/code availability incompleteAssessed

This Αlpha¹ Rigor Review uses AI Rigor Reviewers trained on a curated corpus of high-fidelity and retracted papers, with expert supervision and curation. It can still make mistakes; verify each finding against the source before relying on it.

This is a well-conducted, rigorously reported randomized controlled trial with strong methodology, clear ethics, and transparent reporting. The main weakness is the vague data/code availability, and there are minor internal inconsistencies in reported statistics that warrant correction.

Both reviewers classified the study as interventional; no divergence. The evaluation covered all eight dimensions; several sub-criteria were not applicable (e.g., animal housing, cell lines). The statistics verification covered only a subset of tests (8 recomputed), and the copyedit/integrity checks flagged minor CI/SD inconsistencies that do not affect the overall statistical adequacy rating.

7 major claims checked against the paper's own evidence: 2 not fully backed by the presented evidence (unsupported or overstated), 1 only partially supported (evidence backs part of the claim; gaps or caveats remain).

Premise concern: surrogate not validated for clinical benefit; effect size not shown to be clinically meaningful.

Recomputed 7 tests: 7 consistent, 0 inconsistent; 4 recomputed directly from the reported test statistics, 3 via agent-written checks. 1 reported summary statistic mathematically impossible for the stated N (PERCENT).

3 integrity concerns flagged (0 high).

Reporting

Eight Dimensions7 pass · 1 warn

The introduction cites prior research on gestational diabetes, weight management in type 2 diabetes, and observational studies on gestational weight gain, and builds a logical rationale for testing energy restriction in gestational diabetes. It acknowledges gaps in existing evidence, such as the lack of intervention studies addressing gestational weight gain in this population. Limitations of prior work are implicitly addressed by the study design (e.g., using a whole-diet intervention to enable blinding).

Sub-criteria

prior work citedADEQUATE

premise rationaleADEQUATE

limitations addressedADEQUATE

Per reviewer (2) — the votes behind the verdict

PASSReviewer 1· 90% conf

The paper establishes a clear scientific premise with adequate citation of prior work and a logical rationale for the study.

Evidence

direct quote[Main, paragraphs 1-3]

“Several recent retrospective cohort studies have identified that weight gain below the guidelines, or even weight loss, may improve pregnancy outcomes in women with prepregnancy obesity or gestational diabetes”